Zymeworks - Analysts Project A Big Turnaround By: TalkMarkets February 20, 2024 at 13:38 PM EST Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. Read More >> Related Stocks: Zymeworks Inc. - Common Stock